Key Factor Supporting Gene Editing Market Development in 2025: Role Of Gene Editing In Battling Communicable Diseases

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Gene Editing Market Size Growth Forecast: What to Expect by 2025?
The market size of gene editing has seen a swift expansion in the past years. It is expected to rise from $8.82 billion in 2024 to $10.34 billion in 2025, with a compound annual growth rate (CAGR) of 17.3%. The unprecedented growth during the historic period is due to the discovery of crispr-cas9, advancements in the field of genetic sequencing, medical innovations, funding for scientific research, and the development in the biotech industry.

How Will the Gene Editing Market Size Evolve and Grow by 2029?
The market for gene editing is forecasted to experience fast expansion in the coming years, with a prediction to reach $20.79 billion in 2029, reflecting a compound annual growth rate (CAGR) of 19.1%. The predicted surge during this forecast period is due to the enlargement of therapeutic applications, enhancements in precision, and efficiency, commercialization of gene therapy, development of agricultural applications, and the growth of regenerative medicine. Key trends for the upcoming period include changes in multiplex editing techniques, novel techniques in base editing, gene drives, and alterations in population, the advent of non-viral delivery systems, the use of disease modeling, and the discovery of new drugs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

What Drivers Are Propelling the Growth of Gene Editing Market Forward?
The rise in the prevalence of contagious diseases is giving a boost to the gene editing market by making its techniques essential for detection and treatment. Contagious diseases, which are illnesses that stem from infectious pathogens like bacteria, viruses, or parasites, can be transferred from individual to individual, animals, or the environment. Gene editing technologies are more and more being used to create targeted strategies capable of identifying and fighting these pathogens on a genetic level, thereby improving disease control and prevention efforts. The World Economic Forum, a Swiss-based international non-governmental institution, reported in 2023 that diseases like influenza and respiratory syncytial virus (RSV) have heightened since the pandemic. In the USA, it was estimated in February 2023 that influenza resulted in approximately 24 million sicknesses, 260,000 hospital stays, and 16,000 fatalities. Additionally, based on reports from the World Health Organization in 2022, about 10.6 million people globally were infected with tuberculosis, causing around 1.3 million tuberculosis-related deaths. Therefore, contagious diseases are fueling the advancement of the gene editing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

Which Emerging Trends Are Transforming the Gene Editing Market in 2025?
Leading corporations in the gene editing market are developing innovative tools and techniques, such as a method based on unique cell-penetrating peptides, to secure competitive advantage over rivals. Such progression could also contribute remarkably to the creation of cutting-edge cell therapies for cancer and other diseases. In April 2023, Penn Medicine, an esteemed health system run by multiple hospitals in the United States, discovered that certain viruses use protein fragments to enter cells, which could also be harnessed to transport CRISPR-Cas gene editing molecules into cells and their DNA-filled nuclei with unparalleled efficiency and minimal cellular toxicity. This new process is predicted to be especially beneficial in altering T cells and other cells from a patient's own body to create cell therapies. A potential application could be CAR T (chimeric antigen receptor T cell) therapy that employs customised immune cells from a patient to combat cancer. This fresh perspective on cellular genetic engineering anticipates substantial improvements in speed, efficiency, and a decrease in cellular toxicity compared to existing methods.

What Are the Key Segments in the Gene Editing Market?
The gene editing market covered in this report is segmented -

1) By Technology: CRISPR, TALEN, ZFN
2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering
3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:
1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives
2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits
3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

Who Are the Key Players Shaping the Gene Editing Market's Competitive Landscape?
Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

What Geographic Markets Are Powering Growth in the Gene Editing Market?
North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.